Ethan Eurmsirilerd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ethan Eurmsirilerd has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Guanpeng Wang
Department of Immunology & Theranostics, Arthur Riggs Diabetes & Metabolism Research Institute, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA
1 shared publication Lei Shen
Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Cancer Center, Duarte, CA 91010, USA
1 shared publication- Rendell Chang
Department of Botany & Plant Sciences, University of California, Riverside, CA 92527, USA
1 shared publication - Weirong Shang
Department of Gynecology and Obsterics, School of Medicine, Emory University, Atlanta, GA 30322, USA
1 shared publication - Xiaoqun Tao
Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Cancer Center, Duarte, CA 91010, USA
1 shared publication - Yanzhong Yang
Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Cancer Center, Duarte, CA 91010, USA
1 shared publication
Latest Publications
- Open Access
- 23 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (4) , eaea3960
TDRD3, a Tudor domain-containing protein, regulates Klf2 -dependent T reg differentiation and function to modulate immune tolerance
Tudor domain-containing protein 3 (TDRD3) functions as a methylarginine reader that relays posttranslational arginine methylation signals to the transcriptional machinery, thereby regulating cellular functions through modulation of gene expression. Regulatory T cells (T regs ) are pivotal for establishing and maintaining immune tolerance. In this study, we demonstrate that mice with T reg -specific deletion of Tdrd3 exhibit severely impaired iT reg , but not thymic T reg , differentiation. Moreover, iT regs , but not thymic T regs , derived from these mice fail to suppress colitis in adoptive transfer models, indicating compromised inhibitory capacity. Aged Tdrd3 -deficient mice also show spontaneous autoinflammation. Mechanistically, TDRD3 is recruited by the transcription factor FOXO1, presumably in a methylation-dependent manner, to activate Klf2 expression, which is essential for T reg differentiation. Notably, the enforced expression of Klf2 in Tdrd3 -deficient CD4 + T cells rescue both iT reg development and suppressive function. Collectively, our findings identify TDRD3 as a central transcriptional regulator of iT reg differentiation and immune homeostasis, highlighting it as a potential therapeutic target for modulating immune tolerance.
- 23 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (4) , eaea3960
Open AccessTDRD3, a Tudor domain-containing protein, regulates Klf2 -dependent T reg differentiation and function to modulate immune tolerance
Tudor domain-containing protein 3 (TDRD3) functions as a methylarginine reader that relays posttranslational arginine methylation signals to the transcriptional machinery, thereby regulating cellular functions through modulation of gene expression. Regulatory T cells (T regs ) are pivotal for establishing and maintaining immune tolerance. In this study, we demonstrate that mice with T reg -specific deletion of Tdrd3 exhibit severely impaired iT reg , but not thymic T reg , differentiation. Moreover, iT regs , but not thymic T regs , derived from these mice fail to suppress colitis in adoptive transfer models, indicating compromised inhibitory capacity. Aged Tdrd3 -deficient mice also show spontaneous autoinflammation. Mechanistically, TDRD3 is recruited by the transcription factor FOXO1, presumably in a methylation-dependent manner, to activate Klf2 expression, which is essential for T reg differentiation. Notably, the enforced expression of Klf2 in Tdrd3 -deficient CD4 + T cells rescue both iT reg development and suppressive function. Collectively, our findings identify TDRD3 as a central transcriptional regulator of iT reg differentiation and immune homeostasis, highlighting it as a potential therapeutic target for modulating immune tolerance.